Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic and clinical immunology in uveitis.

R B Nussenblatt1

  • 1National Eye Institute, NIH, Bethesda, Maryland 20892.

Japanese Journal of Ophthalmology
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunopathology of ocular onchocerciasis 3. Th-2 helper T cells in the conjunctiva.

Ocular immunology and inflammation·2012
Same author

Association of Propionibacterium acnes endophthalmitis with HLA-DQw5.

Ocular immunology and inflammation·2012
Same author

Clinical pathologic findings of Propionibacterium acnes endophthalmitis.

Ocular immunology and inflammation·2012
Same author

Inflammatory cellular kinetics in sympathetic ophthalmia a study of 29 traumatized (exciting) eyes.

Ocular immunology and inflammation·2012
Same author

Inhibition of cellular transfer of experimental autoimmune uveoretinitis by Rapamycin.

Ocular immunology and inflammation·2012
Same author

Immunohistochemical localization of T lymphocytes and macrophages and expression of interferon gamma and defensin in uveitis.

Ocular immunology and inflammation·2012
Same journal

Utility of liquid-based cytology and cell block obtained by vitrectomy under infusion to diagnose vitreoretinal lymphoma.

Japanese journal of ophthalmology·2026
Same journal

Geographic atrophy progression and subretinal drusenoid deposits in a real-world Japanese cohort.

Japanese journal of ophthalmology·2026
Same journal

Axial length correction in retinal thickness measurements in diabetic retinopathy.

Japanese journal of ophthalmology·2026
Same journal

Association between the anatomical location of conjunctivochalasis and subjective symptoms: a multicenter retrospective study.

Japanese journal of ophthalmology·2026
Same journal

Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study.

Japanese journal of ophthalmology·2026
Same journal

Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study.

Japanese journal of ophthalmology·2026
See all related articles

Cell-mediated immunity, particularly T-cell responses, is crucial for sight-threatening ocular diseases like uveitis. Cyclosporine, an anti-T-cell drug, effectively treats these conditions, including Behçet uveitis.

Area of Science:

  • Immunology
  • Ophthalmology

Background:

  • Ocular inflammation involves complex immune responses.
  • Traditionally, Type III hypersensitivity was implicated in ocular disease.
  • Emerging evidence highlights cell-mediated immunity in sight-threatening conditions.

Purpose of the Study:

  • To investigate the role of immune mechanisms in ocular inflammation.
  • To explore the importance of cell-mediated immunity in uveitis.
  • To evaluate therapeutic approaches for sight-threatening ocular diseases.

Main Methods:

  • Utilizing experimental models of uveitis (S-antigen and IRBP).
  • Investigating immune cell homing to ocular tissues.
  • Assessing the efficacy of cyclosporine as an anti-T-cell therapy.

Related Experiment Videos

Main Results:

  • Experimental models provide insights into uveitis mechanisms.
  • T-cell mediated mechanisms are critical in sight-threatening ocular diseases.
  • Cyclosporine demonstrates significant efficacy in treating severe uveitis, including Behçet uveitis.

Conclusions:

  • Cell-mediated immunity, especially T-cell responses, plays a major role in uveitis.
  • Cyclosporine is an effective therapeutic agent for sight-threatening ocular inflammatory diseases.
  • Combination therapies are being explored to manage potential side effects like renal toxicity.